Purdue Pharma introduces Butrans Transdermal System CIII
Butrans Transdermal System delivers continuous release of buprenorphine for seven days, Purdue Pharma said. Purdue Pharma has jointly developed a Risk Evaluation and Mitigation Strategy (REMS) for Butrans
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.